-
University of Hong Kong: Timely booster vaccination reduces omicron breakout infections and COVID-19 severity
Time of Update: 2023-02-03
Source: The University of Hong KongResearchers from the AIDS Institute of the Department of Microbiology, The University of Hong Kong's School of Clinical Medicine and the State Key Laboratory of Emerging Infectious Diseases found that timely vaccination with coronavirus vaccine, or BNT162b2 vaccine, is critical for inducing activation of virus-specific memory B cells and omicron cross-reactive T cell responses, significantly reducing the frequency and severity of breakthrough infections.
-
The difference between intravenous human immunoglobulin and COVID-19 human immunoglobulin
Time of Update: 2023-02-01
1. Supplementing the lack of antibodies in the human body intravenous human immunoglobulin is mainly used for the treatment of primary immunoglobulin deficiency and secondary immunoglobulin deficiency diseases (such as severe infection, neonatal sepsis) 。 Intravenous injection of COVID-19 human immune globules can identify the specific antigen of the new coronavirus and weaken its infectivity.
-
EU plastics industry lacks effective sustainability strategy, putting 678 billion euros of investor capital at risk
Time of Update: 2023-02-01
In fact, the new "Breakout" report assumes that business-as-usual models for the plastics industry may be more risky than starting a transition to a sustainable strategy .
-
Global bioplastic production forecast to more than triple in next five years
Time of Update: 2023-01-20
5 million tonnes Biodegradable plastics, including PBAT, PLA and PBS, currently account for more than 64% of global bioplastic production capacity, or 1.
Therefore, there is no competition between renewable raw materials for food and feed and the production of bioplastics, " concludes Hasso von Pogrell, Managing Director of Bioplastics Europe.
-
Officially included in the breakthrough therapy variety! Remegen Taitacept was again recognized for myasthenia gravis
Time of Update: 2023-01-05
About Tatacept Tatanercept is an antibody fusion protein drug molecule invented and designed by Professor Fang Jianmin, CEO and Chief Scientific Officer of Remegen Biologics, which inhibits the overexpression of two cytokines, BLyS and APRIL, and prevents the abnormal differentiation and maturation of B cells, thereby treating B-cell-mediated systemic lupus erythematosus and other autoimmune diseases.
-
EU enforcement review: More than a quarter of waste recyclings do not comply with EU REACH regulation
Time of Update: 2023-01-01
According to Article 2(7)(d) of the EU REACH Regulation, a recovered substance is exempt from EU REACH registration if it is the same substance as the registered substance and has the Safety Data Sheets (SDSs) required by Article 31 or Article 32 of the Regulation or the information transmitted to the downstream supply chain.
-
In 2022, the US FDA approved the in-depth inventory of new drugs
Time of Update: 2022-12-30
The number of 12 new molecular therapies and the proportion of new molecular therapies approved by the FDA reached the highest in nearly 10 years: 5 genetically modified cell and gene therapies, 3 bispecific antibody/protein therapies, 1 RNAi therapy, 1 mRNA vaccine, 1 microbiome therapy and 1 antibody conjugate.
-
Demystifying Gen Z condiment consumption
Time of Update: 2022-12-29
Quick Start: One package of ingredients for a dishThe rib soup base, which used to be simmered for nearly 10 hours, can be easily solved in just 5 minutes with the compound seasoning, and the flavor is no worse than that of expensive restaurants.
-
January 5 copper market afternoon review
Time of Update: 2022-12-24
Copper market midday commentary: a weaker dollar boosted commodity gains, and London copper closed up $40 overnight; The European energy crisis continues to boost the non-ferrous sector, copper market production is weak and inventories remain low, copper is expected to rise.
-
Long and short factors intertwined Copper prices are still dominated by volatility in the near future
Time of Update: 2022-12-24
Overnight, the impact of the U. S. index pulling up the rebound slipped sharply, closing at $9565, down 1. 13%. Powell reiterated his importance to inflation and will implement actions to stop it, the
-
Shanghai rubber contract increased positions and contracted, and futures prices closed slightly lower
Time of Update: 2022-12-23
On Thursday, the Shanghai rubber RU2201 contract increased its position and contracted, and the futures price closed slightly lower.
On Thursday, the Shanghai rubber RU2201 contract increased its position and contracted, and the futures price closed slightly lower.
-
Liansu contract volume reduced position, futures price volatility higher
Time of Update: 2022-12-21
16 million tons) of the total domestic linear PE output.
16 million tons) of the total domestic linear PE output.
16 million tons) of the total domestic linear PE output.
16 million tons) of the total domestic linear PE output.
-
The main shock of Shanghai aluminum rose slightly, and it is expected that the short-term low level adjustment
Time of Update: 2022-12-21
Shanghai aluminumMarket Focus: (1) Yellen will reaffirm her commitment to the market-determined exchange rate at Tuesday's hearing, while Yellen will also make it clear that the United States will not seek a weak dollar to gain a competitive advantage.
-
Shanghai aluminum shock fell slightly and the upper pressure increased
Time of Update: 2022-12-19
In terms of spot, the holder actively ships the goods, the price is relatively strong, the middleman can receive the goods, a large household purchases normally, and the downstream procurement is mainly on-demand.
-
Inventories continue to accumulate Shanghai copper main contract shock adjustment
Time of Update: 2022-12-18
Market focus: (1) The minutes of the Fed meeting show that at the policy meeting that month, Fed officials expressed confidence in the US economy and believed that interest rates are likely to remain unchanged for some time.
